CN115944541A - Multifunctional novel crystal mask with facial partition - Google Patents
Multifunctional novel crystal mask with facial partition Download PDFInfo
- Publication number
- CN115944541A CN115944541A CN202211639640.8A CN202211639640A CN115944541A CN 115944541 A CN115944541 A CN 115944541A CN 202211639640 A CN202211639640 A CN 202211639640A CN 115944541 A CN115944541 A CN 115944541A
- Authority
- CN
- China
- Prior art keywords
- percent
- percentage content
- mask
- extract
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001815 facial effect Effects 0.000 title claims abstract description 171
- 239000013078 crystal Substances 0.000 title claims abstract description 35
- 238000005192 partition Methods 0.000 title claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 97
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 92
- 239000000284 extract Substances 0.000 claims description 70
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 68
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 49
- 102000008186 Collagen Human genes 0.000 claims description 47
- 108010035532 Collagen Proteins 0.000 claims description 47
- 229920001436 collagen Polymers 0.000 claims description 47
- 238000001816 cooling Methods 0.000 claims description 47
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 46
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 46
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 46
- 229920002581 Glucomannan Polymers 0.000 claims description 46
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 46
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 46
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 46
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 46
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 46
- 229940046240 glucomannan Drugs 0.000 claims description 46
- 235000011187 glycerol Nutrition 0.000 claims description 46
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 46
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 46
- 229940101267 panthenol Drugs 0.000 claims description 46
- 235000020957 pantothenol Nutrition 0.000 claims description 46
- 239000011619 pantothenol Substances 0.000 claims description 46
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 46
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 46
- 229940068977 polysorbate 20 Drugs 0.000 claims description 46
- 239000001103 potassium chloride Substances 0.000 claims description 46
- 235000011164 potassium chloride Nutrition 0.000 claims description 46
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 46
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 46
- 239000011701 zinc Substances 0.000 claims description 46
- 229910052725 zinc Inorganic materials 0.000 claims description 46
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 42
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 42
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 42
- 229940112950 sage extract Drugs 0.000 claims description 41
- 235000020752 sage extract Nutrition 0.000 claims description 41
- 239000004615 ingredient Substances 0.000 claims description 40
- 241000206575 Chondrus crispus Species 0.000 claims description 31
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 31
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 31
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 31
- 230000000694 effects Effects 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 26
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 25
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 22
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 22
- 229960002216 methylparaben Drugs 0.000 claims description 22
- 229960003966 nicotinamide Drugs 0.000 claims description 21
- 235000005152 nicotinamide Nutrition 0.000 claims description 21
- 239000011570 nicotinamide Substances 0.000 claims description 21
- 239000003086 colorant Substances 0.000 claims description 12
- 238000005520 cutting process Methods 0.000 claims description 11
- 210000001061 forehead Anatomy 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 241000881711 Acipenser sturio Species 0.000 claims description 6
- 239000000679 carrageenan Substances 0.000 claims description 6
- 235000010418 carrageenan Nutrition 0.000 claims description 6
- 229920001525 carrageenan Polymers 0.000 claims description 6
- 229940113118 carrageenan Drugs 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 5
- 240000007164 Salvia officinalis Species 0.000 claims description 5
- 235000002912 Salvia officinalis Nutrition 0.000 claims description 5
- 235000002020 sage Nutrition 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 238000007493 shaping process Methods 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 235000015067 sauces Nutrition 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 7
- 229910052700 potassium Inorganic materials 0.000 claims 7
- 239000011591 potassium Substances 0.000 claims 7
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims 6
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims 5
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims 5
- 229940041514 candida albicans extract Drugs 0.000 claims 5
- 229940106189 ceramide Drugs 0.000 claims 5
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims 5
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims 5
- 230000011218 segmentation Effects 0.000 claims 5
- 239000012138 yeast extract Substances 0.000 claims 5
- 229940074774 glycyrrhizinate Drugs 0.000 claims 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 235000014103 egg white Nutrition 0.000 claims 1
- 210000000969 egg white Anatomy 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 31
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 15
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 15
- 239000010931 gold Substances 0.000 description 15
- 229910052737 gold Inorganic materials 0.000 description 15
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 11
- 229940012466 egg shell membrane Drugs 0.000 description 11
- 238000000855 fermentation Methods 0.000 description 11
- 230000004151 fermentation Effects 0.000 description 11
- 229940109850 royal jelly Drugs 0.000 description 11
- 244000273256 Phragmites communis Species 0.000 description 10
- 235000014676 Phragmites communis Nutrition 0.000 description 10
- YDSVPIYLRFZLAT-UHFFFAOYSA-N C(C)(=O)O.C(C)(=O)O.NC(CCC(=O)NCC1=CC=CC=C1)N Chemical compound C(C)(=O)O.C(C)(=O)O.NC(CCC(=O)NCC1=CC=CC=C1)N YDSVPIYLRFZLAT-UHFFFAOYSA-N 0.000 description 7
- 101100269850 Caenorhabditis elegans mask-1 gene Proteins 0.000 description 7
- 108010016626 Dipeptides Proteins 0.000 description 7
- 241000235346 Schizosaccharomyces Species 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 241000235070 Saccharomyces Species 0.000 description 5
- 239000006229 carbon black Substances 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 4
- 244000223977 Tuber melanosporum Species 0.000 description 3
- 235000002777 Tuber melanosporum Nutrition 0.000 description 3
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 241000124167 Melanospora Species 0.000 description 1
- 244000143590 Salvia chinensis Species 0.000 description 1
- 235000007154 Salvia chinensis Nutrition 0.000 description 1
- 235000005794 Salvia japonica Nutrition 0.000 description 1
- 241000609666 Tuber aestivum Species 0.000 description 1
- 241000142927 Tuber magnatum Species 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Cosmetics (AREA)
Abstract
The invention provides a multifunctional novel crystal facial mask with facial regions, which comprises a first type facial mask, a second type facial mask, a third type facial mask, a fourth type facial mask, a fifth type facial mask, a sixth type facial mask and a sixth type facial mask, wherein the first type facial mask comprises a first facial mask transparent part, a first facial mask red part, a first facial mask yellow part and a first facial mask black part; the crystal mask improves the appearance novelty of the crystal mask and promotes the multi-effect practicability of the mask.
Description
Technical Field
The invention relates to the field of facial masks, in particular to a novel multifunctional crystal facial mask for facial subareas.
Background
The facial mask is a category of skin care products, is used for moisturizing skin, and also has multiple functions of moisturizing, nourishing, improving appearance, deeply cleaning and the like.
The mask covers the stratum corneum of the skin, provides moisture to the stratum corneum, and enables the stratum corneum to be fully hydrated so as to improve the appearance and the elasticity of the skin; contains humectant and emollient, and has effects in blocking skin, reducing water loss of skin, softening horny layer, and promoting absorption of effective components through skin.
The facial mask can cause skin to shrink moderately in the drying process of water volatilization, and the blocking effect can temporarily raise skin temperature and promote blood circulation.
The facial mask can remove dead skin and dirt on skin surface during peeling or washing process, and has certain cleaning effect.
However, the existing common crystal mask has a single appearance and a single effect, and on the basis, production equipment (the process of extracting a single material body is changed into the process of independently extracting multiple different effect material bodies), a mould (the process of improving the cutting areas and the cutting directions of the different material bodies corresponding to the face) and a production process (the process of respectively preparing the different effect material bodies and then utilizing the improved production equipment to correspond the different effect material bodies to different areas of the face at a high temperature and then cutting the different effect material bodies into the shape of the mask after rapid cooling and shaping) are improved, the crystal mask material bodies with different effects correspond to the face areas with specified effects according to the skin characteristics of the different areas of the face of a human body, different colors can be distinguished, the appearance novelty of the crystal mask is remarkably improved, the practicability of the efficacy of the synergistic mask is promoted, and the crystal mask is attractive and good in appearance.
Disclosure of Invention
In order to make up for the defects, the invention provides a novel multifunctional crystal mask with a facial partition, which can effectively solve the problems that the common crystal mask is single in appearance and single in effect, so that the existing mask can only achieve one effect when in use, and different effects on different areas of the face cannot be achieved.
The invention is realized in the following way:
a multifunctional novel crystal facial mask with a facial partition comprises a first type facial mask, wherein the first type facial mask comprises a first facial mask transparent part, a first facial mask red part, a first facial mask yellow part and a first facial mask black part, the first facial mask transparent part is positioned at the forehead part of a face and is the upper end of the first type facial mask, the first facial mask red part is positioned at the eyes part of the face and is the upper side of the middle part of the first type facial mask, the first facial mask yellow part is positioned at the nose bridge part of the face and is the lower side of the middle part of the first type facial mask, and the first facial mask black part is positioned at the mouth and chin part of the face and is the lower end of the first type facial mask;
the transparent part of the first face film comprises the following ingredients:
1.1 to 2.1 percent of glycerol, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of wrinkled giant carrageenan, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19-0.21%, 0.11-0.13% of polysorbate-20, 0.014-0.016% of sage extract, 0.4-0.6% of hydrolyzed collagen zinc, 1.4-1.6% of nicotinamide, 0.4-0.6% of panthenol, 0.14-0.16% of dipotassium glycyrrhizinate, 0.009-0.011% of crymodynia gigantea extract, 0.009-0.011% of schizosaccharomyces cerevisiae fermentation product extract, 0.009-0.011% of eggshell membrane extract, and the balance of water;
the ingredients of the red part of the first facial mask are as follows:
1.1 to 2.1 percent of glycerol, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of wrinkled giant carrageenan, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.04 to 0.06 percent of CI77, 0.04 to 0.06 percent of CI 77491, 0.009 to 0.06 percent of dipeptide, 0.009 to 0.011 percent of diaminobutyrylbenzylamide diacetate, and the balance of water;
the ingredients of the yellow part of the first facial mask are as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Phragmites communis, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.14 to 0.16 percent of gold, 0.009 to 0.011 percent of ceramide AP, 0.009 to 0.011 percent of royal jelly extract and the balance of water;
the ingredients of the black part of the first mask are as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Phragmites communis, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.049 to 0.051 percent of gold, 0.039 to 0.041 percent of carbon black, 0.009 to 0.011 percent of black fungus extract, 0.009 to 0.011 percent of sturgeon caviar extract and the balance of water.
In one embodiment of the invention, the facial mask further comprises a second type facial mask, the second type facial mask comprises a second facial mask red part, a second facial mask yellow part and a second facial mask transparent part, the second facial mask red part is positioned at the forehead part of the face, namely the upper end of the second type facial mask, the second facial mask yellow part is positioned at the eye part of the face, namely the upper side of the middle part of the second type facial mask, and the second facial mask transparent parts are positioned at the nose bridge and the lower part of the face, namely the lower side and the lower end of the middle part of the second type facial mask;
the ingredients of the red portion of the second facial mask are as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Phragmites communis, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.04 to 0.06 percent of CI77, 0.04 to 0.06 percent of CI 77491, 0.009 to 0.06 percent of dipeptide, 0.009 to 0.011 percent of diaminobutyrylbenzylamide diacetate, and the balance of water;
the ingredients of the yellow part of the second facial mask are as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Phragmites communis, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.14 to 0.16 percent of gold, 0.009 to 0.011 percent of ceramide AP, 0.009 to 0.011 percent of royal jelly extract and the balance of water;
the second panel transparent part comprises the following ingredients:
1.1 to 2.1 percent of glycerol, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of wrinkled giant carrageenan, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.009 to 0.011 percent of melissa alba extract, 0.009 to 0.011 percent of schizosaccharomyces cerevisiae fermentation product extract, 0.009 to 0.011 percent of eggshell membrane extract and the balance of water.
In one embodiment of the invention, the third type facial mask further comprises a third type facial mask, wherein the third type facial mask comprises a third surface yellow part and a third surface transparent part, the third surface yellow part is positioned in the vertical middle part of the face, namely the vertical middle part of the third type facial mask, and the third surface transparent parts are positioned at two sides of the face, namely two sides of the third type facial mask;
the ingredients of the yellow part of the third surface film are as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Phragmites communis, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.14 to 0.16 percent of gold, 0.009 to 0.011 percent of ceramide AP, 0.009 to 0.011 percent of royal jelly extract and the balance of water;
the third transparent part of the surface film comprises the following ingredients:
1.1 to 2.1 percent of glycerol, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of wrinkled giant carrageenan, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.009 to 0.011 percent of crymodynia gigantea extract, 0.009 to 0.011 percent of schizosaccharomyces cerevisiae fermentation product extract, 0.009 to 0.011 percent of eggshell membrane extract and the balance of water.
In an embodiment of the present invention, the fourth type facial mask further includes a fourth face mask, the fourth face mask includes a fourth face mask yellow portion and a fourth face mask transparent portion, the fourth face mask yellow portion is located at an eye portion of the face, that is, at an upper side of a middle portion of the fourth type facial mask, the fourth face mask transparent portion is located at a forehead portion, a nose bridge and a lower portion of the face, that is, at upper and lower ends of the fourth type facial mask;
the ingredients of the yellow part of the fourth face film are as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Phragmites communis, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.14 to 0.16 percent of gold, 0.009 to 0.011 percent of ceramide AP, 0.009 to 0.011 percent of royal jelly extract and the balance of water;
the fourth surface film transparent part comprises the following ingredients:
1.1 to 2.1 percent of glycerol, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of wrinkled giant carrageenan, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.009 to 0.011 percent of crymodynia gigantea extract, 0.009 to 0.011 percent of schizosaccharomyces cerevisiae fermentation product extract, 0.009 to 0.011 percent of eggshell membrane extract and the balance of water.
In one embodiment of the invention, the facial mask further comprises a fifth type facial mask, wherein the fifth type facial mask comprises a fifth facial mask black part and a fifth facial mask transparent part, the fifth facial mask black part is positioned on one side of the face, namely one side of the fifth type facial mask, and the fifth facial mask transparent part is positioned on the other side of the face, namely the other side of the fifth type facial mask;
the ingredients of the black part of the fifth mask are as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Phragmites communis, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.049 to 0.051 percent of gold, 0.039 to 0.041 percent of carbon black, 0.009 to 0.011 percent of black fungus extract, 0.009 to 0.011 percent of sturgeon caviar extract, and the balance of water:
the fifth transparent part of the face film comprises the following ingredients:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Phragmites communis, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.009 to 0.011 percent of crymodynia gigantea extract, 0.009 to 0.011 percent of schizosaccharomyces cerevisiae fermentation product extract, 0.009 to 0.011 percent of eggshell membrane extract and the balance of water.
In one embodiment of the present invention, the present invention further includes a sixth type facial mask, where the sixth type facial mask includes a sixth red portion and a sixth yellow portion, the sixth red portion is located at the bridge of the nose and at the upper portion, i.e. the upper end of the sixth type facial mask, and the sixth yellow portion is located at the lower portion of the bridge of the nose, i.e. the lower end of the sixth type facial mask;
the ingredients of the red part of the sixth film are as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Phragmites communis, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.04 to 0.06 percent of CI77, 0.04 to 0.06 percent of CI 77491, 0.009 to 0.06 percent of dipeptide, 0.009 to 0.011 percent of diaminobutyrylbenzylamide diacetate, and the balance of water;
the sixth film yellow part comprises the following ingredients:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Phragmites communis, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose and 0.25 to 0.3 percent of sodium hyaluronate
0.15-0.17%, EDTA disodium 0.01-0.03%, and methyl hydroxybenzoate
0.19 to 0.21 percent, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.14 to 0.16 percent of dipotassium glycyrrhizinate, 0.14 to 0.16 percent of gold, 0.009 to 0.011 percent of ceramide AP, 0.009 to 0.011 percent of royal jelly extract and the balance of water.
In one embodiment of the present invention, both sides of the upper ends of the first type facial mask, the second type facial mask, the third type facial mask, the fourth type facial mask, the fifth type facial mask and the sixth type facial mask are provided with eye holes, the middle of the middle part is provided with a nasal bridge line groove, and the middle of the lower end is provided with an oral cavity hole.
In one embodiment of the invention, the preparation process further comprises the following steps:
s1, dissolving ingredients with different effects: preparing materials with different efficacies and colors respectively, and keeping the high temperature of 75-80 ℃ for later use;
s2, injecting the mixture into a designated area for cooling and forming: then, respectively and independently pumping the materials with different effects and colors to corresponding designated regions of the face at high temperature by using production equipment, and then rapidly cooling and shaping;
s3, cutting the cooled and formed mask: then selecting a corresponding die to perform cutting forming according to the shape requirement of the facial mask to be cut;
s4, detecting and packaging: and after the appearance quality inspection is qualified, folding the facial mask into a facial mask bag, filling, sealing, packaging a finished product, inspecting the finished product, and warehousing and delivering the qualified product.
In an embodiment of the invention, when the ingredients in S1 are dissolved, a mixer is used to mix and mix, the rotation speed of the mixer is controlled to be 200r/min-500r/min, the prepared ingredient solution and the color material are mixed and stirred, and the mask is divided into different color regions, so that different ingredients are injected into a specific region to achieve cooling and forming.
In one embodiment of the invention, the cooling comprises water cooling, air cooling and cold air cooling, wherein the water cooling realizes circulating delivery of circulating water by adopting a water pump, a delivery pipeline is arranged at the lower part of the model for cooling, the air cooling and the cold air cooling are both cooled by adopting a fan, and room-temperature air is adopted for cooling in comparison with air cooling, and low-temperature air is adopted for cooling in the cold air cooling.
The invention has the beneficial effects that:
the crystal mask has the advantages that the single material body is extracted instead of the multiple different effect material bodies which are independently extracted at the same time, the cutting areas and the cutting directions of the different material bodies corresponding to the face are improved, the production equipment which is improved after the different effect material bodies are respectively prepared and reused corresponds to the different areas of the face at high temperature, the crystal mask material bodies with different effects are quickly cooled and shaped and then cut into the shape of the mask, the crystal mask material bodies with different effects correspond to the face areas with the appointed effects according to the skin characteristics of the different areas of the face of a human body, the different colors can be distinguished, the appearance novelty of the crystal mask is obviously improved, the practicability of the effect-enhancing effect is promoted, the crystal mask is attractive and good, the traditional single appearance and the conventional basic effect of the crystal mask are filled, the face skin is subdivided into the different areas, and the effect of enhancing the effect is improved on the conventional basic effect.
The use of the mask of the present invention can improve various problems of different areas and acupuncture points of the face, such as: forehead lines, sichuan-shaped lines, canthus lines, under-eye bags and dark circles, cheeks, mouth and horn lines, dry face, dark yellow skin, rough skin and the like, and is sensitive and tender.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings that are required to be used in the embodiments will be briefly described below, it should be understood that the following drawings only illustrate some embodiments of the present invention and therefore should not be considered as limiting the scope, and for those skilled in the art, other related drawings can be obtained according to the drawings without inventive efforts.
FIG. 1 is a schematic illustration of a first type of profile film structure of the present invention;
FIG. 2 is a schematic view of a second type of mask construction according to the present invention;
fig. 3 is a schematic view of a third type of mask construction of the present invention;
FIG. 4 is a schematic view of a fourth type of mask construction according to the present invention;
FIG. 5 is a schematic view of a fifth type of mask construction according to the present invention;
fig. 6 is a schematic view of a sixth type of mask construction according to the present invention;
FIG. 7 is a schematic flow chart of the process steps of the present invention.
In the figure: 1-a first type of mask; 101-first face film transparent; 102-first facial mask red portion; 103-first facial mask yellow; 104-first facial mask black portion; 2-a second type mask; 201-second facial film red portion; 202-second facial film yellow; 203-second panel transparency; 3-a third type mask; 301-third face film yellow; 302-third face film transparent; 4-a fourth type of mask; 401-fourth facial film yellow; 402-a fourth side film transparent portion; 5-fifth type mask; 501-fifth mask black area; 502-fifth mask clear section; 6-sixth type mask; 601-red section of sixth film; 602-sixth film yellow; 603-eye hole; 604-nose line slot; 605-oral cavity hole;
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention more apparent, the technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings of the embodiments of the present invention. All other embodiments, which can be obtained by a person skilled in the art without any inventive step based on the embodiments of the present invention, are within the scope of the present invention.
Referring to fig. 1-7, the present invention provides a technical solution:
the first embodiment is as follows:
the novel multifunctional crystal facial mask comprises a first type facial mask 1, wherein the first type facial mask 1 comprises a first facial mask transparent part 101, a first facial mask red part 102, a first facial mask yellow part 103 and a first facial mask black part 104, the first facial mask transparent part 101 is located at the forehead part of a face, namely the upper end of the first type facial mask 1, the first facial mask red part 102 is located at the eyes part of the face, namely the upper side of the middle part of the first type facial mask 1, the first facial mask yellow part 103 is located at the nose bridge part of the face, namely the lower side of the middle part of the first type facial mask 1, and the first facial mask black part 104 is located at the mouth and chin parts of the face, namely the lower end of the first type facial mask 1;
the ingredients of the first transparent part 101 of the face film are as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of trufflera cordifolia extract is 0.01%, the percentage content of saccharomyces bifida fermentation product extract is 0.01%, the percentage content of eggshell membrane extract is 0.01%, and the balance is water;
the first facial film red portion 102 is formulated as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of CI77019 is 0.05%, the percentage content of CI 77491 is 0.05%, the percentage content of dipeptide diaminobutyryl benzylamide diacetate is 0.01%, and the balance is water;
the ingredients of the first mask yellow portion 103 are as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispa is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methyl hydroxybenzoate is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of gold is 0.15%, the percentage content of ceramide AP is 0.01%, the percentage content of royal jelly extract is 0.01%, and the balance is water;
the ingredients of the first facial mask black portion 104 are as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of gold is 0.05%, the percentage content of carbon black is 0.04%, the percentage content of tuber melanosporum extract is 0.01%, the percentage content of sturgeon sauce extract is 0.01%, and the balance is water.
The second embodiment:
the novel multifunctional crystal facial mask with the facial area also comprises a second type facial mask 2, wherein the second type facial mask 2 comprises a second facial mask red part 201, a second facial mask yellow part 202 and a second facial mask transparent part 203, the second facial mask red part 201 is positioned at the forehead part of the face, namely the upper end of the second type facial mask 2, the second facial mask yellow part 202 is positioned at the eyes part of the face, namely the upper side of the middle part of the second type facial mask 2, and the second facial mask transparent part 203 is positioned at the nose bridge and the lower part of the face, namely the lower side and the lower end of the middle part of the second type facial mask 2;
the ingredients of the second facial film red portion 201 are as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of CI77019 is 0.05%, the percentage content of CI 77491 is 0.05%, the percentage content of dipeptide diaminobutyryl benzylamide diacetate is 0.01%, and the balance is water;
the second facial mask yellow 202 was formulated as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of gold is 0.15%, the percentage content of ceramide AP is 0.01%, the percentage content of royal jelly extract is 0.01%, and the balance is water;
the second panel transparency 203 is formulated as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of cryloysitum album extract is 0.01%, the percentage content of saccharomyces bifidus fermentation product extract is 0.01%, the percentage content of eggshell membrane extract is 0.01%, and the balance is water.
Example three:
the novel multifunctional crystal mask with the face partitioned further comprises a third type mask 3, wherein the third type mask 3 comprises a third mask yellow part 301 and a third mask transparent part 302, the third mask yellow part 301 is located in the vertical middle of the face, namely the vertical middle of the third type mask 3, and the third mask transparent parts 302 are located on two sides of the face, namely the two sides of the third type mask 3;
the ingredients of the third surface film yellow part 301 are as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispa is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methyl hydroxybenzoate is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of gold is 0.15%, the percentage content of ceramide AP is 0.01%, the percentage content of royal jelly extract is 0.01%, and the balance is water;
the third side film transparent portion 302 is formulated as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of cryloysitum album extract is 0.01%, the percentage content of saccharomyces bifidus fermentation product extract is 0.01%, the percentage content of eggshell membrane extract is 0.01%, and the balance is water.
Example four:
the novel multifunctional crystal facial mask with the facial subareas further comprises a fourth type facial mask 4, wherein the fourth type facial mask 4 comprises a fourth surface mask yellow part 401 and a fourth surface mask transparent part 402, the fourth surface mask yellow part 401 is positioned at the eye part of the face, namely the upper side of the middle part of the fourth type facial mask 4, and the fourth surface mask transparent part 402 is positioned at the forehead part, the nose bridge and the lower part of the face, namely the upper end and the lower end of the fourth type facial mask 4;
the ingredients of the fourth film yellow part 401 are as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of gold is 0.15%, the percentage content of ceramide AP is 0.01%, the percentage content of royal jelly extract is 0.01%, and the balance is water;
the fourth transparent film part 402 is prepared as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of cryloysitum album extract is 0.01%, the percentage content of saccharomyces bifidus fermentation product extract is 0.01%, the percentage content of eggshell membrane extract is 0.01%, and the balance is water.
Example five:
the multifunctional novel crystal facial mask with the facial subareas further comprises a fifth type facial mask 5, wherein the fifth type facial mask 5 comprises a fifth facial mask black part 501 and a fifth facial mask transparent part 502, the fifth facial mask black part 501 is positioned on one side of a face, namely one side of the fifth type facial mask 5, and the fifth facial mask transparent part 502 is positioned on the other side of the face, namely the other side of the fifth type facial mask 5;
the ingredients of the fifth mask black part 501 are as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of Chondrus crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methyl hydroxybenzoate is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of gold is 0.05%, the percentage content of carbon black is 0.04%, the percentage content of Tuber melanosporum extract is 0.01%, the percentage content of sturgeon sauce extract is 0.01%, the balance water:
the fifth transparent part 502 of the mask is prepared as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of cryloysitum album extract is 0.01%, the percentage content of saccharomyces bifidus fermentation product extract is 0.01%, the percentage content of eggshell membrane extract is 0.01%, and the balance is water.
Example six:
the novel multifunctional crystal facial mask with the facial regions further comprises a sixth type facial mask 6, wherein the sixth type facial mask 6 comprises a sixth red portion 601 and a sixth yellow portion 602, the sixth red portion 601 is located at the bridge of the nose and at the upper portion, namely the upper end of the sixth type facial mask 6, and the sixth yellow portion 602 is located at the lower portion of the bridge of the nose, namely the lower end of the sixth type facial mask 6;
the ingredients of the sixth film red portion 601 are as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of CI77019 is 0.05%, the percentage content of CI 77491 is 0.05%, the percentage content of dipeptide diaminobutyryl benzylamide diacetate is 0.01%, and the balance is water;
the sixth film yellow portion 602 is prepared as follows:
the percentage content of glycerin is 2%, the percentage content of 1, 2-hexanediol is 1%, the percentage content of carrageen crispus is 1.5%, the percentage content of potassium chloride is 0.8%, the percentage content of glucomannan is 1.2%, the percentage content of hydroxyethyl cellulose is 0.28%, the percentage content of sodium hyaluronate is 0.16%, the percentage content of disodium EDTA is 0.02%, the percentage content of methylparaben is 0.2%, the percentage content of polysorbate-20 is 0.12%, the percentage content of sage extract is 0.015%, the percentage content of hydrolyzed collagen zinc is 0.5%, the percentage content of nicotinamide is 1.5%, the percentage content of panthenol is 0.5%, the percentage content of dipotassium glycyrrhizinate is 0.15%, the percentage content of gold is 0.15%, the percentage content of ceramide AP is 0.01%, the percentage content of royal jelly extract is 0.01%, and the balance is water.
The first type mask 1, the second type mask 2, the third type mask 3, the fourth type mask 4, the fifth type mask 5 and the sixth type mask 6 are provided with eye holes 603 on both sides of the upper end, a nose bridge line groove 604 is provided in the middle of the middle part, and an oral hole 605 is provided in the middle of the lower end.
Water as solvent, glycerin as humectant, 1, 2-hexanediol as humectant, chondrus CRISPUS (Chondrus CRISPUS) as skin conditioner, potassium chloride as thickener, glucomannan as skin conditioner, hydroxyethyl cellulose as thickener, sodium hyaluronate as skin conditioner, disodium EDTA as chelating agent, methylparaben as preservative, polysorbate-20 as solubilizer, salvia officinalis (Salvia JAPONICA) extract as skin conditioner, hydrolyzed collagen zinc as skin conditioner, nicotinamide as skin conditioner, panthenol as skin conditioner, and dipotassium glycyrrhizinate as skin conditioner;
gold as a colorant, ceramide AP as a skin conditioner, royal jelly extract as a skin conditioner, carbon black as a colorant, tuber MELANOSPORUM (TUBER melanospora) extract as a skin conditioner, sturgeon caviar extract as a skin conditioner, truffle (TUBER MAGNATUM) extract as a skin conditioner, schizosaccharomyces cerevisiae fermentation product extract as a skin conditioner, eggshell membrane extract as a skin conditioner, CI77019 as a colorant, CI 77491 as a colorant, dipeptide diaminobutyrylbenzyl amide diacetate as a skin conditioner.
The working principle and the using process of the invention are as follows:
firstly, dissolving ingredients with different effects: respectively preparing materials with different effects and colors, keeping the temperature at 75-80 ℃ for later use, stirring and mixing the materials by using a stirrer when the materials are dissolved, controlling the rotating speed of the stirrer at 200-500 r/min, mixing and stirring the prepared material solution and the color materials, dividing the facial mask by a set color region, and injecting different materials into a specific region to realize cooling and forming;
and secondly, injecting the mixture into a specified area for cooling and forming: then, respectively and independently pumping the materials with different effects and colors to corresponding designated areas of the face by using production equipment at high temperature, and then carrying out rapid cooling and shaping, wherein the cooling comprises water cooling, air cooling and cold air cooling, the water cooling adopts a water pump to realize circulating delivery of circulating water, a delivery pipeline is arranged at the lower part of the model to carry out cooling, the air cooling and the cold air cooling both adopt fans to carry out cooling, and room-temperature air is adopted for cooling in comparison with the air cooling, and the cold air cooling adopts low-temperature air for cooling;
thirdly, cutting the cooled and formed mask: then selecting a corresponding die to perform cutting forming according to the shape requirement of the facial mask to be cut;
fourthly, detecting and packaging: and after the appearance quality inspection is qualified, folding the product into a mask bag, filling and sealing the product, packaging the product, inspecting the product, and warehousing and delivering the product after the product is qualified.
The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (10)
1. The multifunctional novel crystal mask with the facial area is characterized by comprising a first type of mask (1), wherein the first type of mask (1) comprises a first mask transparent part (101), a first mask red part (102), a first mask yellow part (103) and a first mask black part (104), the first mask transparent part (101) is located at the forehead part of a face, namely the upper end of the first type of mask (1), the first mask red part (102) is located at the eyes part of the face, namely the upper side of the middle part of the first type of mask (1), the first mask yellow part (103) is located at the nose bridge part of the face, namely the lower side of the middle part of the first type of mask (1), and the first mask black part (104) is located at the mouth and the chin part of the face, namely the lower end of the first type of mask (1);
the first face film transparent part (101) comprises the following ingredients:
1.1-2.1 percent of glycerin, 0.9-1.1 percent of 1, 2-hexanediol, 1.4-1.6 percent of Chondrus crispus, 0.7-0.9 percent of potassium chloride, 1.1-1.3 percent of glucomannan, 0.25-0.3 percent of hydroxyethyl cellulose, 0.15-0.17 percent of sodium hyaluronate, 0.01-0.03 percent of disodium EDTA, 0.19-0.21 percent of methylparaben, 0.11-0.13 percent of polysorbate-20, 0.014-0.016 percent of sage extract, 0.014-0.016 percent of hydrolyzed collagen zinc, 0.4-0.6 percent of nicotinamide, 1.4-1.6 percent of panthenol, 0.4-0.6 percent of dipotassium glycyrrhizinate, 0.009-0.011 percent of yeast extract, and the balance of fermented egg white fungus extract;
the first facial film red part (102) is prepared by the following ingredients:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 0.4 to 1.6 percent of carrageen crispa, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose, 0.15 to 0.17 percent of sodium hyaluronate, 0.01 to 0.03 percent of disodium EDTA, 0.19 to 0.21 percent of methylparaben, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.019 to 0.774 percent of potassium glycyrrhizinate, 0.7704 percent of diaminobenzylalkide, and the balance of butyrylamide, 0.1.1 to 2.1.1 percent of butyrylamide, 0.4 to 0.6 percent of potassium dihydrobutyrylamide, 0.7791.1.1 to 0.1.6 percent of dibutyrylamide, and the balance of dibutyrylamide;
the ingredients of the first mask yellow part (103) are as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Chondrus crispus, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose, 0.15 to 0.17 percent of sodium hyaluronate, 0.01 to 0.03 percent of disodium EDTA, 0.19 to 0.21 percent of methyl hydroxybenzoate, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.014 to 0.011 percent of dipotassium glycyrrhizinate, 0.16 to 0.009 percent of AP and 0.16 to 16 percent of ceramide, the balance being water extract;
the first mask black part (104) is prepared by the following steps:
the weight percentage content of glycerin is 1.1-2.1%, the weight percentage content of 1, 2-hexanediol is 0.9-1.1%, the weight percentage content of wrinkled giant-style carrageenan is 1.4-1.6%, the weight percentage content of potassium chloride is 0.7-0.9%, the weight percentage content of glucomannan is 1.1-1.3%, the weight percentage content of hydroxyethyl cellulose is 0.25-0.3%, the weight percentage content of sodium hyaluronate is 0.15-0.17%, the weight percentage content of disodium EDTA is 0.01-0.03%, the weight percentage content of methyl hydroxybenzoate is 0.19-0.21%, the weight percentage content of polysorbate-20 is 0.11-0.13%, the weight percentage content of sage extract is 0.014-0.016%, the weight percentage content of hydrolyzed collagen zinc is 0.4-0.046%, the weight percentage content of nicotinamide is 1.4-1.6%, the weight percentage content of panthenol is 0.4-0.6%, the weight percentage content of dipotassium glycyrrhizinate is 0.14-0.041%, the weight percentage content of hydrolyzed collagen is 0.16-0.046%, the weight percentage content of black fungus extract is 0.011%, the weight percentage content of sturgeon black fungus sauce is 0.039-0.011%, the balance.
2. The multifunctional novel crystal facial mask with the facial part as claimed in claim 1, characterized by further comprising a second type facial mask (2), wherein the second type facial mask (2) comprises a second facial mask red part (201), a second facial mask yellow part (202) and a second facial mask transparent part (203), the second facial mask red part (201) is located at the forehead part of the face, namely the upper end of the second type facial mask (2), the second facial mask yellow part (202) is located at the eyes part of the face, namely the upper middle side of the second type facial mask (2), and the second facial mask transparent part (203) is located at the nose bridge and the lower part of the face, namely the lower middle side and the lower end of the second type facial mask (2);
the second facial film red portion (201) is formulated as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 0.4 to 1.6 percent of carrageen crispa, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose, 0.15 to 0.17 percent of sodium hyaluronate, 0.01 to 0.03 percent of disodium EDTA, 0.19 to 0.21 percent of methylparaben, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.019 to 0.774 percent of potassium glycyrrhizinate, 0.7704 percent of diaminobenzylalkide, and the balance of butyrylamide, 0.1.1 to 2.1.1 percent of butyrylamide, 0.4 to 0.6 percent of potassium dihydrobutyrylamide, 0.7791.1.1 to 0.1.6 percent of dibutyrylamide, and the balance of dibutyrylamide;
the second facial film yellow section (202) is formulated as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Chondrus crispus, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose, 0.15 to 0.17 percent of sodium hyaluronate, 0.01 to 0.03 percent of disodium EDTA, 0.19 to 0.21 percent of methyl hydroxybenzoate, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.014 to 0.011 percent of dipotassium glycyrrhizinate, 0.16 to 0.009 percent of AP and 0.16 to 16 percent of ceramide, the balance being water extract;
the second panel transparency (203) is formulated as follows:
the percentage content of glycerin is 1.1-2.1%, the percentage content of 1, 2-hexanediol is 0.9-1.1%, the percentage content of Chondrus crispus is 1.4-1.6%, the percentage content of potassium chloride is 0.7-0.9%, the percentage content of glucomannan is 1.1-1.3%, the percentage content of hydroxyethyl cellulose is 0.25-0.3%, the percentage content of sodium hyaluronate is 0.15-0.17%, the percentage content of disodium EDTA is 0.01-0.03%, the percentage content of methylparaben is 0.19-0.21%, the percentage content of polysorbate-20 is 0.11-0.13%, the percentage content of Salvia officinalis extract is 0.014-0.016%, the percentage content of hydrolyzed collagen zinc is 0.4-0.6%, the percentage content of nicotinamide is 1.4-1.6%, the percentage content of panthenol is 0.4-0.6%, the percentage content of dipotassium glycyrrhizinate is 0.014-0.011%, the percentage content of yeast extract is 0.009-0.011%, the percentage content of kokui-0.009%, and the balance is 0.009%.
3. The multifunctional novel crystal mask with the face partitioned according to claim 2, characterized by further comprising a third type mask (3), wherein the third type mask (3) comprises a third mask yellow portion (301) and a third mask transparent portion (302), the third mask yellow portion (301) is located in the vertical middle of the face, namely the vertical middle of the third type mask (3), and the third mask transparent portions (302) are located on two sides of the face, namely two sides of the third type mask (3);
the third surface film yellow part (301) comprises the following ingredients:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Chondrus crispus, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose, 0.15 to 0.17 percent of sodium hyaluronate, 0.01 to 0.03 percent of disodium EDTA, 0.19 to 0.21 percent of methyl hydroxybenzoate, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.014 to 0.011 percent of dipotassium glycyrrhizinate, 0.16 to 0.009 percent of AP and 0.16 to 16 percent of ceramide, the balance being water extract;
the third transparent film part (302) is prepared by the following steps:
the percentage content of glycerin is 1.1-2.1%, the percentage content of 1, 2-hexanediol is 0.9-1.1%, the percentage content of Chondrus crispus is 1.4-1.6%, the percentage content of potassium chloride is 0.7-0.9%, the percentage content of glucomannan is 1.1-1.3%, the percentage content of hydroxyethyl cellulose is 0.25-0.3%, the percentage content of sodium hyaluronate is 0.15-0.17%, the percentage content of disodium EDTA is 0.01-0.03%, the percentage content of methylparaben is 0.19-0.21%, the percentage content of polysorbate-20 is 0.11-0.13%, the percentage content of Salvia officinalis extract is 0.014-0.016%, the percentage content of hydrolyzed collagen zinc is 0.4-0.6%, the percentage content of nicotinamide is 1.4-1.6%, the percentage content of panthenol is 0.4-0.6%, the percentage content of dipotassium glycyrrhizinate is 0.014-0.011%, the percentage content of yeast extract is 0.009-0.011%, the percentage content of kokui-0.009%, and the balance is 0.009%.
4. The multifunctional novel crystal mask for facial subdivision according to claim 3, characterized by further comprising a fourth type mask (4), wherein the fourth type mask (4) comprises a fourth surface yellow part (401) and a fourth surface transparent part (402), the fourth surface yellow part (401) is located at the eye part of the face, namely the upper middle part of the fourth type mask (4), and the fourth surface transparent part (402) is located at the forehead part, the nose bridge and the lower part of the face, namely the upper and lower ends of the fourth type mask (4);
the fourth film yellow part (401) comprises the following ingredients:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Chondrus crispus, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose, 0.15 to 0.17 percent of sodium hyaluronate, 0.01 to 0.03 percent of disodium EDTA, 0.19 to 0.21 percent of methyl hydroxybenzoate, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.014 to 0.011 percent of dipotassium glycyrrhizinate, 0.16 to 0.009 percent of AP and 0.16 to 16 percent of ceramide, the balance being water extract;
the fourth surface film transparent part (402) is prepared by the following steps:
the percentage content of glycerin is 1.1-2.1%, the percentage content of 1, 2-hexanediol is 0.9-1.1%, the percentage content of Chondrus crispus is 1.4-1.6%, the percentage content of potassium chloride is 0.7-0.9%, the percentage content of glucomannan is 1.1-1.3%, the percentage content of hydroxyethyl cellulose is 0.25-0.3%, the percentage content of sodium hyaluronate is 0.15-0.17%, the percentage content of disodium EDTA is 0.01-0.03%, the percentage content of methylparaben is 0.19-0.21%, the percentage content of polysorbate-20 is 0.11-0.13%, the percentage content of Salvia officinalis extract is 0.014-0.016%, the percentage content of hydrolyzed collagen zinc is 0.4-0.6%, the percentage content of nicotinamide is 1.4-1.6%, the percentage content of panthenol is 0.4-0.6%, the percentage content of dipotassium glycyrrhizinate is 0.014-0.011%, the percentage content of yeast extract is 0.009-0.011%, the percentage content of kokui-0.009%, and the balance is 0.009%.
5. The multifunctional novel crystal mask with the face partition as claimed in claim 4, further comprising a fifth type mask (5), wherein the fifth type mask (5) comprises a fifth mask black part (501) and a fifth mask transparent part (502), the fifth mask black part (501) is located on one side of the face, namely one side of the fifth type mask (5), and the fifth mask transparent part (502) is located on the other side of the face, namely the other side of the fifth type mask (5);
the ingredients of the fifth mask black part (501) are as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 0.4 to 1.6 percent of Chondrus crispus, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose, 0.15 to 0.17 percent of sodium hyaluronate, 0.01 to 0.03 percent of disodium EDTA, 0.19 to 0.21 percent of methylparaben, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.041 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.041 percent of panthenol, 0.011 to 0.049 percent of potassium glycyrrhizinate, 0.030 to 0.011 percent of Acipenserin extract, 0.049 to 0.049 percent of Acipenserin extract, 0.049 to 0.011 percent of Acipenserin extract, and the balance of Acipenserin extract: the fifth transparent part (502) of the face film comprises the following ingredients:
the percentage content of glycerin is 1.1-2.1%, the percentage content of 1, 2-hexanediol is 0.9-1.1%, the percentage content of Chondrus crispus is 1.4-1.6%, the percentage content of potassium chloride is 0.7-0.9%, the percentage content of glucomannan is 1.1-1.3%, the percentage content of hydroxyethyl cellulose is 0.25-0.3%, the percentage content of sodium hyaluronate is 0.15-0.17%, the percentage content of disodium EDTA is 0.01-0.03%, the percentage content of methylparaben is 0.19-0.21%, the percentage content of polysorbate-20 is 0.11-0.13%, the percentage content of Salvia officinalis extract is 0.014-0.016%, the percentage content of hydrolyzed collagen zinc is 0.4-0.6%, the percentage content of nicotinamide is 1.4-1.6%, the percentage content of panthenol is 0.4-0.6%, the percentage content of dipotassium glycyrrhizinate is 0.14-0.009%, the percentage content of white collyrium album extract is 0.009-0.009%, the percentage content of Schizoctonia-0.011%, the percentage content of Megassum of yeast extract is 0.011%, and the balance is 0.011%.
6. The multifunctional novel crystal mask with facial segmentation according to claim 5, further comprising a sixth type mask (6), wherein the sixth type mask (6) comprises a sixth red mask portion (601) and a sixth yellow mask portion (602), the sixth red mask portion (601) is located at the bridge of the nose and at the upper portion, i.e. at the upper end of the sixth type mask (6), and the sixth yellow mask portion (602) is located at the lower portion of the bridge of the nose, i.e. at the lower end of the sixth type mask (6);
the ingredients of the red part (601) of the sixth film are as follows:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 0.4 to 1.6 percent of carrageen crispa, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose, 0.15 to 0.17 percent of sodium hyaluronate, 0.01 to 0.03 percent of disodium EDTA, 0.19 to 0.21 percent of methylparaben, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.019 to 0.774 percent of potassium glycyrrhizinate, 0.7704 percent of diaminobenzylalkide, and the balance of butyrylamide, 0.1.1 to 2.1.1 percent of butyrylamide, 0.4 to 0.6 percent of potassium dihydrobutyrylamide, 0.7791.1.1 to 0.1.6 percent of dibutyrylamide, and the balance of dibutyrylamide;
the sixth film yellow part (602) is prepared by the following steps:
1.1 to 2.1 percent of glycerin, 0.9 to 1.1 percent of 1, 2-hexanediol, 1.4 to 1.6 percent of Chondrus crispus, 0.7 to 0.9 percent of potassium chloride, 1.1 to 1.3 percent of glucomannan, 0.25 to 0.3 percent of hydroxyethyl cellulose, 0.15 to 0.17 percent of sodium hyaluronate, 0.01 to 0.03 percent of disodium EDTA, 0.19 to 0.21 percent of methyl hydroxybenzoate, 0.11 to 0.13 percent of polysorbate-20, 0.014 to 0.016 percent of sage extract, 0.4 to 0.6 percent of hydrolyzed collagen zinc, 1.4 to 1.6 percent of nicotinamide, 0.4 to 0.6 percent of panthenol, 0.014 to 0.011 percent of dipotassium glycyrrhizinate, 0.16 to 0.009 percent of AP and 0.16 to 16 percent of ceramide, the balance.
7. The multifunctional novel crystal mask with facial segmentation according to claim 6, characterized in that the first type mask (1), the second type mask (2), the third type mask (3), the fourth type mask (4), the fifth type mask (5) and the sixth type mask (6) are provided with eye holes (603) on both sides of the upper ends, a nose bridge line groove (604) in the middle of the middle part and an oral hole (605) in the middle of the lower end.
8. The multifunctional novel crystal mask for facial segmentation according to claim 1, characterized by further comprising the following preparation processes:
s1, dissolving ingredients with different effects: preparing materials with different efficacies and colors respectively, and keeping the high temperature of 75-80 ℃ for later use;
s2, injecting the mixture into a designated area for cooling and forming: then, respectively and independently pumping the materials with different effects and colors to corresponding designated areas of the face by using production equipment at high temperature, and then rapidly cooling and shaping;
s3, cutting the cooled and formed mask: then selecting a corresponding die to perform cutting forming according to the shape requirement of the facial mask to be cut;
s4, detecting and packaging: and after the appearance quality inspection is qualified, folding the product into a mask bag, filling and sealing the product, packaging the product, inspecting the product, and warehousing and delivering the product after the product is qualified.
9. The novel multifunctional crystal mask for facial segmentation according to claim 8, wherein when the ingredients in S1 are dissolved, a stirrer is used for stirring and mixing, the rotation speed of the stirrer is controlled to be 200r/min-500r/min, the prepared ingredient solution and the color material are mixed and stirred, and the mask is divided into different color regions, so that different ingredients are injected into specific regions to achieve cooling and forming.
10. The multifunctional novel crystal mask for facial segmentation according to claim 9, wherein the cooling comprises water cooling, air cooling and cold air cooling, the water cooling realizes circulating water circulation transportation by using a water pump, a transportation pipeline is arranged at the lower part of the model for cooling, the air cooling and the cold air cooling are both cooled by using a fan, and the difference is that room temperature air is used for cooling with the air cooling, and the cold air cooling uses low temperature air for cooling.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211639640.8A CN115944541A (en) | 2022-12-20 | 2022-12-20 | Multifunctional novel crystal mask with facial partition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211639640.8A CN115944541A (en) | 2022-12-20 | 2022-12-20 | Multifunctional novel crystal mask with facial partition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115944541A true CN115944541A (en) | 2023-04-11 |
Family
ID=87289023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211639640.8A Pending CN115944541A (en) | 2022-12-20 | 2022-12-20 | Multifunctional novel crystal mask with facial partition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115944541A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN204521645U (en) * | 2014-11-10 | 2015-08-05 | 广州市博卡利生物科技有限公司 | A kind of four color facial films |
CN111565598A (en) * | 2017-11-21 | 2020-08-21 | 菲力格林公司 | Facial mask for facial care |
CN112641636A (en) * | 2020-10-16 | 2021-04-13 | 诺斯贝尔化妆品股份有限公司 | Partitioned nursing type mask and preparation process thereof |
CN213553876U (en) * | 2020-08-13 | 2021-06-29 | 李云佩 | Membrane-liquid separation type partition mask set |
-
2022
- 2022-12-20 CN CN202211639640.8A patent/CN115944541A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN204521645U (en) * | 2014-11-10 | 2015-08-05 | 广州市博卡利生物科技有限公司 | A kind of four color facial films |
CN111565598A (en) * | 2017-11-21 | 2020-08-21 | 菲力格林公司 | Facial mask for facial care |
CN213553876U (en) * | 2020-08-13 | 2021-06-29 | 李云佩 | Membrane-liquid separation type partition mask set |
CN112641636A (en) * | 2020-10-16 | 2021-04-13 | 诺斯贝尔化妆品股份有限公司 | Partitioned nursing type mask and preparation process thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106176286A (en) | Hyaluronic acid skin nursing film and preparation method and application | |
CN107496309A (en) | Antiallergic Face-protecting mask | |
CN105055299A (en) | Whitening and skin protecting emulsion | |
KR20130045724A (en) | Composition for flexible sheet mask and method for preparing the sheet mask using the same | |
CN105287331A (en) | Anti-wrinkle cleansing lotion and preparation method thereof | |
CN106466235A (en) | A kind of cleansing powder | |
CN107496255A (en) | A kind of Noni fruit facial mask and preparation method thereof | |
CN106389139A (en) | Acne-removing, mark-eliminating and skin-protecting multifunctional preparation and preparation method thereof | |
CN113143792A (en) | Moisturizing repair cream for repairing skin barrier and preparation method thereof | |
CN115944541A (en) | Multifunctional novel crystal mask with facial partition | |
CN106511227A (en) | Skincare facial mask containing silk peptide and preparation method of skincare facial mask | |
CN114246805A (en) | A facial mask containing vitamin C and its preparation method | |
CN104958223A (en) | Collagen mask | |
CN107714604A (en) | A kind of Yi degree face mask of traditional Chinese medicine and preparation method thereof | |
CN109718141A (en) | A kind of facial mask containing ginkgo biloba p.e | |
CN116531485A (en) | Preparation method of human anti-aging cell substance | |
CN110236972A (en) | A kind of high-content amino acid cleansing cream and preparation method thereof | |
CN110037836A (en) | Bionical adopted cream of a kind of patch skin and preparation method thereof | |
CN105213203A (en) | A kind of preparation method of microcapsule-type moisturizing eye cream | |
CN104398412A (en) | Sweet tea moisturizer and preparation method thereof | |
CN111494242B (en) | Simulated egg appearance mask and preparation method thereof | |
CN107468612A (en) | A kind of tremella face mask and preparation method thereof | |
CN114306204A (en) | Pure natural spirulina polypeptide mask and preparation method thereof | |
CN114588084A (en) | Black eye removing, relieving and wrinkle resisting composition, eye mask and preparation method of eye mask | |
CN112604027A (en) | Nutrient solution for comprehensively solving facial collapse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |